| |
| |
|
| Insider
Information: |
Robb Gary Charles |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
20,203 |
|
|
Indirect Shares
|
25,100 |
|
|
| Direct
Value |
$513,156 |
|
|
|
Indirect Value
|
$637,540 |
|
|
| Total
Shares |
45,303 |
|
|
| Total
Value |
$1,150,696 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
10
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
| Percentage
Gain/Loss : |
0.0%
|
 -2.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-03-01 |
20,203 |
2024-03-01 |
25,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Financial OfficerOfficer |
• – – |
2011-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,258 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-05-04 |
4 |
B |
$9.75 |
$54,588 |
D/D |
5,600 |
6,858 |
2.74 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-09-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,460 |
820 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-12-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,244 |
1,568 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
S |
$19.01 |
$475,153 |
D/D |
(25,000) |
6,858 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
OE |
$1.92 |
$48,000 |
D/D |
25,000 |
21,858 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-26 |
4 |
GA |
$0.00 |
$0 |
D/D |
1,167 |
8,025 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,501 |
2,735 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-12-09 |
4 |
OE |
$1.92 |
$57,600 |
D/D |
30,000 |
38,025 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-12-09 |
4 |
S |
$13.73 |
$412,029 |
D/D |
(30,000) |
8,025 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-11-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,487 |
4,564 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-22 |
4 |
D |
$28.06 |
$7,260,216 |
D/D |
(258,739) |
201,138 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-22 |
4 |
OE |
$2.70 |
$1,220,000 |
D/D |
451,852 |
459,877 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-02-11 |
4 |
S |
$29.78 |
$101,249 |
D/D |
(3,400) |
197,738 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-02-12 |
4 |
S |
$28.22 |
$3,163,899 |
D/D |
(112,100) |
85,638 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-04-23 |
4 |
AS |
$24.02 |
$240,219 |
D/D |
(10,000) |
75,638 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2021-08-30 |
4 |
D |
$21.53 |
$1,742,595 |
D/D |
(80,938) |
142,848 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2021-08-30 |
4 |
OE |
$2.70 |
$400,000 |
D/D |
148,148 |
223,786 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2021-09-13 |
4 |
S |
$20.89 |
$132,445 |
D/D |
(6,341) |
136,507 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2021-09-14 |
4 |
S |
$20.76 |
$16,736 |
D/D |
(806) |
135,701 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2021-09-15 |
4 |
S |
$20.49 |
$980,742 |
D/D |
(47,853) |
87,848 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-03-17 |
4 |
AS |
$24.68 |
$185,374 |
D/D |
(7,512) |
76,434 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-03-18 |
4 |
AS |
$24.67 |
$123,054 |
D/D |
(4,988) |
71,446 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-05-17 |
4 |
S |
$19.55 |
$561,965 |
D/D |
(28,745) |
42,701 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-05-18 |
4 |
S |
$19.55 |
$2,502 |
D/D |
(128) |
42,573 |
0 |
% |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
